Author
University of California Davis Medical CenterPrimary ORCID profile (0000-0002-2381-124X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
Yoko K. Takada, Xueson Wu, David Wei…·Yoshikazu Takada
This study shows FGF2 activates integrin αIIbβ3 via site 2, while FGF1 binds site 2 but inhibits FGF2-induced activation, suggesting FGF1's anti-thrombotic mechanism.
Yoko K. Takada, Xueson Wu, David Wei…·Yoshikazu Takada
This study shows FGF2 activates αvβ3 integrin via site 2, while FGF1 binds site 2 but suppresses integrin activation, suggesting FGF1's anti-inflammatory action is through blocking site 2.
Chih-Chieh Chang, Yoko K. Takada, Chao‐Wen Cheng…·Yoshikazu Takada
This study identifies FGF9 as a new ligand for integrin αvβ3 and shows that a mutant defective in integrin binding acts as an antagonist by suppressing FGF9 signaling.